Back to Search
Start Over
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
- Source :
-
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31075. Date of Electronic Publication: 2024 May 19. - Publication Year :
- 2024
-
Abstract
- Severe aplastic anemia (SAA) is a rare potentially fatal hematologic disorder. Although overall outcomes with treatment are excellent, there are variations in management approach, including differences in treatment between adult and pediatric patients. Certain aspects of treatment are under active investigation in clinical trials. Because of the rarity of the disease, some pediatric hematologists may have relatively limited experience with the complex management of SAA. The following recommendations reflect an up-to-date evidence-based approach to the treatment of children with relapsed or refractory SAA.<br /> (© 2024 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.)
Details
- Language :
- English
- ISSN :
- 1545-5017
- Volume :
- 71
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Pediatric blood & cancer
- Publication Type :
- Academic Journal
- Accession number :
- 38764170
- Full Text :
- https://doi.org/10.1002/pbc.31075